Pediatric Cancer Research Foundation Hosts Fifth International Symposium
“Every school day, approximately 46 children—or two classrooms of students—are diagnosed with cancer across the United States alone.”
Jennifer Riekert, M.B.A.
Vice President of Communications
New York Medical College
International Pediatric Cancer Professionals Converge in Italy for the Four-Day Event
Valhalla, N.Y., October 22, 2015—The Pediatric Cancer Research Foundation (PCRF), in connection with New York Medical College (NYMC), today launched the fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma in Varese, Italy at the Centro Congressi Ville Ponti. Spanning four days, this symposium is held every three years and is designed to present the latest scientific and clinical advances in childhood, adolescent and young adult Non-Hodgkin Lymphoma treatment and research, including biopathology, genomics, stem cell transplantation, immunobiology, translational biology and novel therapeutics.
Featuring speakers from a multidisciplinary, diverse group comprised of basic scientists, translational biologists and clinical investigators, the conference includes formal didactic presentations, informal discussion panels, oral abstract presentations, poster discussions and poster presentations. The program is designed for a global audience of medical and pediatric oncologists, stem and immune cell transplantation investigators, hematopathologists, basic scientists, oncology nurses, physicians-in-training, including fellows, residents and post-docs and other associated health professionals.
Forty-two countries will be represented by attendees. Oral presenters from NYMC faculty include Mitchell Cairo M.D.—NYMC professor of pediatrics, medicine, pathology, microbiology, immunology and cell biology; NYMC associate chairman to the Department of Pediatrics; and chief of pediatric hematology, oncology and stem cell transplantation at Maria Fareri Children’s Hospital at Westchester Medical Center—as well as Jessica Hochberg M.D., Nader El-Mallawany M.D. and Yaya Chu Ph.D., who are assistant professors of pediatrics at NYMC.
“Every school day, approximately 46 children—or two classrooms of students—are diagnosed with cancer across the United States alone,” said Dr. Cairo. “While we have made great strides towards improving the care, quality of life and survival rates of children with malignant diseases, there is still a long way to go on both national and global scales. We are thankful to our attendees and participants from six continents at the event to learn, share their experiences and work together for a cure.”
The full schedule for the symposium can be accessed here:http://www.pcrf-kids.org.
About Pediatric Cancer Research Foundation (PCRF)
The Pediatric Cancer Research Foundation (PCRF) is an independent, nonprofit organization, wholly dedicated to funding leading-edge pediatric cancer research nationwide. Since its founding in 1982, PCRF has raised over $34 million dollars towards the ultimate goal of ending pediatric cancers so children and their families can re-focus on the joys of childhood. This commitment has translated into immediate treatment for children with cancer by developing innovative treatment protocols; improving patients’ long-term quality of life; and supporting those scientists working on the precipice of important medical breakthroughs. For more information, please visit www.pcrf-kids.org or contact Executive Director Jeri Wilson at firstname.lastname@example.org.
About New York Medical College
Founded in 1860, NYMC is one of the oldest and largest health sciences colleges in the country with more than 1,400 students, 1,300 residents and clinical fellows, nearly 3,000 faculty members, and 16,000 living alumni. The College, which joined the Touro College and University System in 2011, is located in Westchester County, New York, and offers advanced degrees from the School of Medicine, the Graduate School of Basic Medical Sciences, and the School of Health Sciences and Practice. The College manages more than $32.6 million in research and other sponsored programs, notably in the areas of cancer, cardiovascular disease, infectious diseases, kidney disease, the neurosciences, disaster medicine, and vaccine development. With a network of affiliated hospitals that includes large urban medical centers, small suburban clinics and high-tech regional tertiary care facilities, NYMC provides a wide variety of clinical training opportunities throughout the tri-state region for medical students, residents, and other health providers. For more information, visit www.nymc.edu.